Fonterra Co-Operative Group Limited v N.V. Nutricia

Link copied
Case Copied 49 min read

IP AUSTRALIA

AUSTRALIAN PATENT OFFICE

Fonterra Co-Operative Group Limited v N.V. Nutricia [2018] APO 38

Patent Application:                   2011353251

Title:Non-medical increase or maintenance of body weight of a mammal

Patent Applicant:  N.V. Nutricia

Opponent:  Fonterra Co-Operative Group Limited

Delegate:  Dr S. J. Smith

Decision Date:  19 June 2018

Hearing Date:  Written submissions filed 23 February 2018, final date for submissions expired 2 March 2018

Catchwords:  PATENTS – opposition to the grant of a patent under section 59 – grounds of clarity, support, disclosure, novelty, inventive step and utility – regulation 5.23 considered – all grounds unsuccessful – costs awarded against opponent

Representation:  Patent attorney for the applicant: FB Rice

Patent attorney for the opponent: AJ Park

IP AUSTRALIA

AUSTRALIAN PATENT OFFICE

Patent Application:                   2011353251

Title:Non-medical increase or maintenance of body weight of a mammal

Patent Applicant:  N.V. Nutricia

Date of Decision:  19 June 2018

DECISION

The opposition is unsuccessful.  Subject to appeal, I direct the application proceed to grant.

I award costs according to Schedule 8 against Fonterra Co-Operative Group Limited.

REASONS FOR DECISION

Background

  1. Patent application 2011353251 was filed by N.V. Nutricia (the Applicant) on 11 August 2011 under the provisions of the Patent Cooperation Treaty.  The application claims priority from PCT/NL2010/050892 which was filed on 28 December 2010.

  2. Acceptance of the application was advertised on 5 May 2016.  Fonterra Co-Operative Group Limited (the Opponent) filed a notice of opposition under section 59 of the Patents Act 1990 (the Act) on 5 August 2016.

  3. The statement of grounds and particulars (SGP) was filed on 7 November 2016 and identifies the following grounds of opposition: novelty, inventive step, utility, sufficiency, support and clarity.

  4. The Applicant proposed post-acceptance amendments to the specification on 5 May 2017 which were allowed unopposed on 29 September 2017 and this decision therefore relates to the specification as amended. 

  5. The evidence filed during the evidentiary periods is summarised in the table below:

Evidence Declarant Exhibits Declaration Date Reference

In Support

Angela Rowan

-

7 February 2017

Rowan

Christine Lennon Buchan

CLB-1 to CLB-9

7 February 2017

Buchan

In Answer

Ladislaus Maria Broersen

EIA-1 to EIA-2

1 May 2017

Broersen

  1. The request for examination of the opposed application was filed on 23 January 2015.  Consequently, the amendments of the Act brought about by the Intellectual Property Laws Amendment (Raising the Bar) Act 2012 (the Raising the Bar Act) apply to the present application. This includes section 60(3A) of the Act, which provides that the Commissioner may refuse an application if satisfied on the balance of probabilities that a ground of opposition exists.  It is the opponent who carries the onus of proof.

  2. The Opponent elected not to make any submissions in the hearing.  The Applicant accordingly directed its submissions to the grounds of opposition identified in the SGP and I will decide the opposition as particularised.  This approach is somewhat complicated by the fact that the claims have been amended quite significantly and the Opponent’s evidence and particulars are not directed…

CaseChat AU logo

Keep reading for free

Create a free CaseChat account to read Fonterra Co-Operative Group Limited v N.V. Nutricia and more:

  • Read every judgment in full
  • Ask AI and get answers linked to paragraphs
  • See how each paragraph was cited in later cases
  • Download judgments as PDF or Word
Continue with Google

One click creates your free account or signs you in.

By continuing you agree to the Terms and Privacy Policy.

Details
Case
[2018] APO 38
Decision Date

CaseChat Overview and Summary

The opposition to the grant of a patent for a composition comprising at least four components, selected from the group of: a uridine source; n-3 polyunsaturated fatty acids selected from the group of DHA, DPA and EPA; vitamins B selected from the group of vitamin B6, vitamin B9 and vitamin B12; phospholipids; antioxidants selected from the group of vitamin C, vitamin E and selenium; and cholines, with the proviso that at least one uridine source, DHA, one vitamin B and one phospholipid is present, for increasing or maintaining the body weight of a human, wherein the composition is administered to the human in a diet without essentially increasing the daily caloric intake of the human, said human being an elderly person of the age of 50 or more, was unsuccessful. The Commissioner found that the claims were clear, novel, inventive, supported by the specification, and useful. The Commissioner awarded costs against the opponent.

Orders

Orders of the court

Background

Background to the litigation

Evidence

Evidence Before The Court

Decision

Reasons for decision

Ratio Decidendi

Legal Principle Established